RECRUITING

Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.

Official Title

Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Quick Facts

Study Start:2024-07-09
Study Completion:2027-04-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06395428

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 - 65 years old
  2. * Presenting to the Bronson ED with a chief complaint of acute, non-traumatic back pain
  3. * VAS score \>5 cm
  1. * Back pain due to traumatic injury
  2. * Experiencing saddle anesthesia
  3. * Has bowel or bladder dysfunction
  4. * Has an abnormal neurological exam
  5. * Requires imaging in ED
  6. * Has a Glascow coma score \<15
  7. * Has one or more abnormal vital signs:
  8. * Has an allergy to ketorolac or haloperidol
  9. * Has a known diagnosis of Lewy Body Dementia
  10. * Has a known diagnosis of glaucoma.
  11. * Is known to be pregnant or breastfeeding
  12. * Is a prisoner or ward of the state
  13. * Is unable to consent for themselves/ non-english speaking
  14. * In the opinion of the attending physician or investigator the patient should not participate in the research

Contacts and Locations

Study Contact

Jessica McCoy, MD
CONTACT
269-337-6600
jessica.mccoy@wmed.edu
Katharine Mitchell, MA
CONTACT
269-341-8364
mitckath@bronsonhg.org

Principal Investigator

Jessica McCoy, MD
PRINCIPAL_INVESTIGATOR
Western Michigan University Homer Stryker M.D. School of Medicine

Study Locations (Sites)

Bronson Methodist Hospital
Kalamazoo, Michigan, 49007
United States

Collaborators and Investigators

Sponsor: Western Michigan University School of Medicine

  • Jessica McCoy, MD, PRINCIPAL_INVESTIGATOR, Western Michigan University Homer Stryker M.D. School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-09
Study Completion Date2027-04-15

Study Record Updates

Study Start Date2024-07-09
Study Completion Date2027-04-15

Terms related to this study

Keywords Provided by Researchers

  • Haloperidol
  • Chronic Pain
  • Back Pain

Additional Relevant MeSH Terms

  • Back Pain
  • Chronic Pain